Combinations of tumor and treatment parameters are more discriminative for prognosis than the present TNM system in rectal cancer

Journal of Clinical Oncology

Volumn 25, Issue 13, 2007, Pages 1647-1650

  Nagtegaal, Iris D ^a   Gosens, Marleen J E M ^a   Marijnen, Corrie A M ^b   Rutten, Harm J ^c   Van De Velde, Cornelis J H ^d   Van Krieken, J Han J M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c CATHARINA HOSPITAL   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; HUMAN; LYMPH NODE METASTASIS; METASTASIS; NOTE; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER; RECTUM RESECTION; SURVIVAL RATE;

CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS;

EID: 34249055553     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.4825     Document Type: Note

References (25)

1. Kapiteijn E, Marijnen CAM, Nagtegaai ID, et al: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638-646, 2001
2. Swedish Rectal Cancer Trial: Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336:980-987, 1997
3. Sebag-Montefiore D, Steele R, Quirke P, et al: Routine short course preoperative radiotherapy or selective postoperative chemoradiotherapy for resectable rectal cancer? Preliminary results of the MRC CR07 randomized trial. J Clin Oncol 24:148s, 2006 (abstr 3511)
4. Gerard JP, Conroy T, Bonnetain F, et al: Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 24:4620-4625, 2006
5. Bosset JF, Collette L, Calais, et al: Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114-1123, 2006
6. Dukes CE: The classification of cancer of the rectum. J Pathol Bacteriol 35:323-332, 1932
7. Sobin LH, Wittekind C: TNM Classification of Malignant Tumours (ed 6). New York, NY, John Wiley, 2002
8. Greene FL, Page D, Fleming ID, et al: AJCC Staging Handbook (ed 6). New York, NY, Springer, 2002
9. Rodel C, Martus P, Papadoupolos T: Prognostic significance of tumour regression after preoperative chemoradiation for rectal cancer. J Clin Oncol 23:8688-8696, 2006
10. Bouzourene H, Bosman FT, Seelentag W, et al: Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer 94:1121-1130, 2002
11. Ryan R, Gibbons D, Hyland JM, et al: Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology 47:141-146, 2005
12. Gosens MJEM, Van Krieken JH, Rutten H, et al: A critical appraisal of therapy induced tumor regression in rectal carcinoma. Ann Oncol 17:P62, 2006
13. Quirke P, Sebag-Montefiore D, Steele R, et al: Local recurrence after rectal cancer resection is strongly related to the plane of surgical dissection and is further reduced by preoperative short course radiotherapy: Preliminary results of the MRC CR07 trial. J Clin Oncol 24:149s, 2006 (abstr 3512)
14. Nagtegaal ID, van de Velde CJH, van der Worp E, et al: Macroscopic evaluation of rectal cancer resection specimen: Clinical significance of the pathologist in quality control. J Clin Oncol 20:1729-1734, 2002
15. Jeruss JS, Mittendorf EA, Tucker SL, et al: Should pathological response to neoadjuvant therapy be incorporated into the AJCC staging system for breast cancer? Breast Cancer Res Treat 100:s259, 2006
16. Das P, Skibber JM, Rodriguez-Bigas MA, et al: Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol 29:219-224, 2006
17. Kim NK, Baik SH, Seong JS, et al: Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival. Ann Surg 244:1024-1030, 2006
18. Beresford M, Glynne-Jones R, Richman P, et al: The reliability of lymphnode staging in rectal cancer after preoperative chemoradiotherapy. Clin Oncol (R Coll Radiol) 17:448-455, 2005
19. Mawdsley S, Glynne-Jones R, Grainger J, et al: Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival? Int J Radiat Oncol Biol Phys 63:745-752, 2005
20. Bouzourene H, Bosman FT, Matter M, et al: Predictive factors in locally advanced rectal cancer treated with preoperative hyperfractionated and accelerated radiotherapy. Hum Pathol 34:541-548, 2003
21. Machiels JP, Aydin S, Bonny MA, et al: What is the best way to predict disease-free survival after preoperative radiochemotherapy for rectal cancer patients: Tumor regression grading, nodal status, or circumferential resection margin invasion? J Clin Oncol 24:1319, 2006
22. Quirke P, Dixon MF: How I do it: The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorectal Dis 3:127-131, 1988
23. Quirke P, Morris E: Reporting colorectal cancer. Histopathology 50:103-112, 2007
24. Gosens M, van Krieken JHJM, Marijnen, CAM, et al: Improvement of staging by combining tumour and treatment parameters: The value for prognostication in rectal cancer. Clin Gastroenterol Hepatol (in press)
25. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al: Sphincter preservation following preoperative radiotherapy for rectal cancer: Report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 72:15-24, 2004